Eli Lilly Tirzepatide - Search News

News

Lilly Sues 4 Compounders Over Copies of Weight-Loss Drugs

CNBC on MSN · 32m

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

Reuters on MSN · 1h

Lilly sues four compounders over copies of weight-loss drugs

Eli Lilly said on Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S. judge last month blocked pharmacies from making copies of its weight-loss and diabetes medicines.

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

Eli Lilly opens a new legal front in its battle against compounded GLP-1s

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Endpoints News2h

Eli Lilly sues four telehealth companies selling compounded tirzepatide

Eli Lilly on Thursday filed lawsuits against four telehealth companies over their sale of compounded versions of the GLP-1 ...

4don MSN

Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

11dOpinion

Eli Lilly Tries to Kill Custom Tirzepatide--But This Healthtech Rebel Isn't Backing Down

OrderlyMeds fights back after Big Pharma crackdown, igniting a battle over the future of personalized medicine ...

Long-term weight regain minimal with tirzepatide for adults with obesity, prediabetes

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...

5don MSN

Where Will Eli Lilly Be in 5 Years?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

1h

Is Eli Lilly Stock a Buy?

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

Dramatic Uptake of Tirzepatide Seen for T2D and Weight Loss

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

15h

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results